長期投資家のためのIR情報
バリュートレンド

【4544】H.U.グループホールディングス
臨床検査薬、受託臨床検査。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2025.03 2024/11/08 Q2予 241,000 0.0% 0.0% 10,000 0.0% 0.0% 8,500 -10.5% -10.5% 5,000 -28.6% -28.6%
2025.03 2024/08/08 Q1予 241,000 0.0% 0.0% 10,000 0.0% 0.0% 9,500 0.0% 0.0% 7,000 0.0% 0.0%
2025.03 2024/05/10 当初予 241,000 - - - 10,000 - - - 9,500 - - - 7,000 - - -
2024.03 2024/05/10 236,950 +0.0% -3.3% -4,043 +1.4% -128.9% -7,241 -2.0% -160.3% -7,553 -2.1% -225.9%
2024.03 2024/04/26 修正予 236,900 -1.3% -3.3% -4,100 -202.5% -129.3% -7,100 -384.0% -159.2% -7,400 - -223.3%
2024.03 2024/02/09 Q3予 240,000 0.0% -2.0% 4,000 0.0% -71.4% 2,500 0.0% -79.2% 0 - -100.0%
2024.03 2023/11/09 Q2予 240,000 -2.0% -2.0% 4,000 -71.4% -71.4% 2,500 -79.2% -79.2% 0 -100.0% -100.0%
2024.03 2023/08/08 Q1予 245,000 0.0% 0.0% 14,000 0.0% 0.0% 12,000 0.0% 0.0% 6,000 0.0% 0.0%
2024.03 2023/05/12 当初予 245,000 - - - 14,000 - - - 12,000 - - - 6,000 - - -
2023.03 2023/05/12 260,908 -0.8% +2.7% 23,381 -10.1% +11.3% 22,010 -7.9% +22.3% 15,676 -9.9% +25.4%
2023.03 2023/02/08 Q3予 263,000 +1.2% +3.5% 26,000 +13.0% +23.8% 23,900 +14.9% +32.8% 17,400 +10.1% +39.2%
2023.03 2022/11/09 Q2予 260,000 +2.4% +2.4% 23,000 +9.5% +9.5% 20,800 +15.6% +15.6% 15,800 +26.4% +26.4%
2023.03 2022/08/09 Q1予 254,000 0.0% 0.0% 21,000 0.0% 0.0% 18,000 0.0% 0.0% 12,500 0.0% 0.0%
2023.03 2022/05/12 当初予 254,000 - - - 21,000 - - - 18,000 - - - 12,500 - - -
2022.03 2022/05/12 272,944 +2.1% +12.8% 50,490 +14.7% +98.0% 47,422 +11.6% +86.0% 29,599 +9.6% +79.4%
2022.03 2022/02/08 Q3予 267,300 +4.9% +10.5% 44,000 +23.9% +72.5% 42,500 +26.1% +66.7% 27,000 +14.9% +63.6%
2022.03 2021/11/09 Q2予 254,700 +2.3% +5.2% 35,500 +18.3% +39.2% 33,700 +20.4% +32.2% 23,500 +34.3% +42.4%
2022.03 2021/08/10 Q1予 249,000 +2.9% +2.9% 30,000 +17.6% +17.6% 28,000 +9.8% +9.8% 17,500 +6.1% +6.1%
2022.03 2021/05/14 当初予 242,000 - - - 25,500 - - - 25,500 - - - 16,500 - - -
2021.03 2021/05/14 223,016 -0.2% +6.2% 25,392 -4.2% +56.3% 25,458 -0.2% +56.7% 17,468 +2.8% +51.9%
2021.03 2021/02/08 Q3予 223,500 +6.4% +6.4% 26,500 +47.2% +63.1% 25,500 +54.5% +56.9% 17,000 +47.8% +47.8%
2021.03 2020/11/10 Q2予 210,000 0.0% 0.0% 18,000 +10.8% +10.8% 16,500 +1.5% +1.5% 11,500 - - -
2021.03 2020/09/18 当初予 210,000 - - - 16,250 - - - 16,250 - - - - - - -
2020.03 2020/05/13 188,712 +0.0% -1.2% 9,939 +0.4% -31.5% 6,468 +15.5% -44.7% -516 +60.3% -106.8%
2020.03 2020/04/24 修正予 188,700 -1.2% -1.2% 9,900 -16.1% -31.7% 5,600 -36.4% -52.1% -1,300 -124.5% -117.1%
2020.03 2020/02/10 Q3予 191,000 0.0% 0.0% 11,800 -18.6% -18.6% 8,800 -24.8% -24.8% 5,300 -30.3% -30.3%
2020.03 2019/11/11 Q2予 191,000 0.0% 0.0% 14,500 0.0% 0.0% 11,700 0.0% 0.0% 7,600 0.0% 0.0%
2020.03 2019/08/08 Q1予 191,000 0.0% 0.0% 14,500 0.0% 0.0% 11,700 0.0% 0.0% 7,600 0.0% 0.0%
2020.03 2019/05/14 当初予 191,000 - - - 14,500 - - - 11,700 - - - 7,600 - - -
2019.03 2019/05/14 181,415 +0.0% -4.5% 14,648 +0.3% -22.9% 11,524 +0.2% -28.0% 6,386 +1.4% -39.2%
2019.03 2019/04/26 修正予 181,400 -4.5% -4.5% 14,600 -23.2% -23.2% 11,500 -28.1% -28.1% 6,300 -40.0% -40.0%
2019.03 2019/02/08 Q3予 190,000 0.0% 0.0% 19,000 0.0% 0.0% 16,000 0.0% 0.0% 10,500 0.0% 0.0%
2019.03 2018/11/01 Q2予 190,000 0.0% 0.0% 19,000 0.0% 0.0% 16,000 0.0% 0.0% 10,500 0.0% 0.0%
2019.03 2018/07/31 Q1予 190,000 - - - 19,000 - - - 16,000 - - - 10,500 - - -
2018.03 2018/02/02 Q3予 199,500 0.0% -5.7% 22,600 0.0% +6.1% 21,500 0.0% +6.4% 8,000 0.0% -20.0%
2018.03 2017/11/20 修正予 199,500 0.0% -5.7% 22,600 0.0% +6.1% 21,500 0.0% +6.4% 8,000 -51.5% -20.0%
2018.03 2017/10/31 Q2予 199,500 0.0% -5.7% 22,600 0.0% +6.1% 21,500 0.0% +6.4% 16,500 0.0% +65.0%
2018.03 2017/09/22 修正予 199,500 -5.7% -5.7% 22,600 +6.1% +6.1% 21,500 +6.4% +6.4% 16,500 +65.0% +65.0%
2018.03 2017/08/01 Q1予 211,500 0.0% 0.0% 21,300 0.0% 0.0% 20,200 0.0% 0.0% 10,000 0.0% 0.0%
2018.03 2017/05/11 当初予 211,500 - - - 21,300 - - - 20,200 - - - 10,000 - - -
2017.03 2017/05/11 204,245 +0.0% -1.8% 28,057 +0.2% +6.7% 26,385 +0.3% +6.2% 333 +11.0% -97.5%
2017.03 2017/04/28 修正予 204,200 -0.1% -1.8% 28,000 +0.7% +6.5% 26,300 +3.1% +5.8% 300 -90.0% -97.8%
2017.03 2017/02/02 Q3予 204,500 0.0% -1.7% 27,800 0.0% +5.7% 25,500 0.0% +2.6% 3,000 0.0% -77.8%
2017.03 2016/10/31 Q2予 204,500 0.0% -1.7% 27,800 0.0% +5.7% 25,500 0.0% +2.6% 3,000 0.0% -77.8%
2017.03 2016/10/13 修正予 204,500 -1.7% -1.7% 27,800 +5.7% +5.7% 25,500 +2.6% +2.6% 3,000 -77.8% -77.8%
2017.03 2016/07/29 Q1予 208,000 0.0% 0.0% 26,300 0.0% 0.0% 24,850 0.0% 0.0% 13,500 0.0% 0.0%
2017.03 2016/04/28 当初予 208,000 - - - 26,300 - - - 24,850 - - - 13,500 - - -
2016.03 2016/04/28 211,743 +0.8% +0.8% 26,050 +1.4% -6.0% 23,782 -2.9% -11.8% -5,081 +12.4% -130.1%
2016.03 2016/02/09 Q3予 210,000 0.0% 0.0% 25,700 0.0% -7.2% 24,500 0.0% -9.1% -5,800 0.0% -134.3%
2016.03 2016/01/27 修正予 210,000 0.0% 0.0% 25,700 0.0% -7.2% 24,500 0.0% -9.1% -5,800 -138.9% -134.3%
2016.03 2015/10/30 Q2予 210,000 0.0% 0.0% 25,700 -7.2% -7.2% 24,500 -9.1% -9.1% 14,900 -11.8% -11.8%
2016.03 2015/07/31 Q1予 210,000 0.0% 0.0% 27,700 0.0% 0.0% 26,950 0.0% 0.0% 16,900 0.0% 0.0%
2016.03 2015/05/01 当初予 210,000 - - - 27,700 - - - 26,950 - - - 16,900 - - -
2015.03 2015/05/01 204,667 -3.7% -3.7% 27,012 -2.1% -2.1% 26,566 -3.0% -3.0% 16,002 +0.6% +0.6%
2015.03 2015/02/03 Q3予 212,500 0.0% 0.0% 27,600 0.0% 0.0% 27,400 0.0% 0.0% 15,900 0.0% 0.0%
2015.03 2014/10/31 Q2予 212,500 0.0% 0.0% 27,600 0.0% 0.0% 27,400 0.0% 0.0% 15,900 0.0% 0.0%
2015.03 2014/08/01 Q1予 212,500 0.0% 0.0% 27,600 0.0% 0.0% 27,400 0.0% 0.0% 15,900 0.0% 0.0%
2015.03 2014/05/02 当初予 212,500 - - - 27,600 - - - 27,400 - - - 15,900 - - -
2014.03 2014/05/02 203,371 - - - 26,727 - - - 27,118 - - - 15,322 - - -
ページトップへ戻る